How many courses of venetoclax/venetoclax tablets should be taken in total?

Venetoclax/Venetoclax (Venetoclax) is a potent, selective, orally administered small molecule B-cell lymphoma 2 inhibitor used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL) and acute myeloid leukemia (AML). These cancers affect a patient's blood cells. With all three diseases, cancer cells take up a lot of space in the bone marrow. This prevents the bone marrow from making enough healthy blood cells. Cancer cells multiply faster and survive longer than healthy blood cells.

Each patient has a different severity of illness and will respond differently to medications. Some patients may require longer treatment to control their condition, while others may see significant results in a shorter period of time. If you have SLL or CLL, you can take venetoclax for up to 1 year. If you have acute myeloid leukemia, you can take venetoclax as long as you and your doctor think it is safe to take it. Patients should discuss with their doctor how long they should take venetoclax. This is because the patient's physical condition also affects the length of the treatment. For example, patients who are older or in poor health may need more careful adjustments to drug dosage and duration to ensure the safety and effectiveness of treatment.

In addition, the therapeutic effect of venetoclax also needs to be regularly evaluated so that doctors can adjust the treatment plan according to changes in the condition. This includes observing the patient's symptom improvement, changes in blood routine indicators, and possible adverse reactions. Therefore, the determination of the course of treatment is a dynamic process that needs to be continuously adjusted according to the actual situation of the patient.